UNSPSC 51262906: Procinolol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SLJ0HIL21J. European Medicines Agency schedules Procinolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10060MIG. Procinolol generally arises in the molecular formula C15H23NO2.

UNSPSC 51262906 Procinolol is a Commodity code that does not align with the recent state and local solicitation activity posted under it. The single identified opportunity—Seminole County, Florida's IFB for naloxone and drug deactivation systems—involves procurement of emergency medical supplies and harm-reduction equipment unrelated to procinolol, a beta-blocking pharmaceutical used in cardiovascular treatment. The mismatch suggests either a coding error in the county's tagging or that the code is not currently being used for its nominal pharmaceutical scope in active state and local procurement.

Seminole County's naloxone and drug deactivation systems IFB, posted June 30, 2026 with responses due July 26, 2023, requested 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carried a two-year term with one-year renewal option, fixed-fee pricing, E-Verify compliance, drug-free workplace certification, and potential FEMA funding with associated federal compliance requirements. No other recent opportunities under UNSPSC 51262906 appear in current state and local procurement records. The code does not show active procurement velocity in the state and local market at present.